Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Exp Clin Psychopharmacol. 2020 Apr 16;29(1):1–13. doi: 10.1037/pha0000373

Figure 5:

Figure 5:

Mean (N=7 / group; SEM) body temperature following vapor inhalation of the PG vehicle or THC (100 mg/mL in the PG) for 30 minutes. Treatment conditions included an injection of vehicle or SR141716 (SR; 4 mg/kg, i.p.) 15 minutes prior to vapor initiation. Open symbols indicate a significant difference from both PG (within respective pre-treatment) at a given time-point and the within-treatment baseline, while shaded symbols indicate a significant difference from the baseline only. A difference from the PG condition (within respective pre-treatment, but not the baseline, is indicated by *. Base: Baseline 30 minutes prior to vapor initiation. SR: SR141716; Veh: Vehicle.